Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion type Assertion NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_head.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion wasGeneratedBy ECO_0000203 NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion wasDerivedFrom befree-2016 NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion SIO_000772 22012255 NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion evidence source_evidence_literature NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.
- NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932256.RAwt5ZdYsOX74J4O1PHuzUuOcpuUwphwsBzdQrEzohCfo130_provenance.